We are live on ! Find out more
TIL icon

Instil Bio

78 hedge funds and large institutions have $1.27B invested in Instil Bio in 2022 Q1 according to their latest regulatory filings, with 11 funds opening new positions, 24 increasing their positions, 19 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

26% more repeat investments, than reductions

Existing positions increased: 24 | Existing positions reduced: 19

10% more first-time investments, than exits

New positions opened: 11 | Existing positions closed: 10

1% more funds holding

Funds holding: 7778 (+1)

0.07% more ownership

Funds ownership: 4.5%4.57% (+0.07%)

17% less funds holding in top 10

Funds holding in top 10: 65 (-1)

36% less capital invested

Capital invested by funds: $1.99B → $1.27B (-$717M)

Holders
78
Holders Change
+1
Holders Change %
+1.3%
% of All Funds
1.23%
Holding in Top 10
5
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-16.67%
% of All Funds
0.08%
New
11
Increased
24
Reduced
19
Closed
10
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
CF
51
CNA Financial
Illinois
$244K
Handelsbanken Fonder
52
Handelsbanken Fonder
Sweden
$236K
VOYA Investment Management
53
VOYA Investment Management
Georgia
$224K +$22.2K +95 +10%
M&T Bank
54
M&T Bank
New York
$170K +$15.2K +65 +9%
Victory Capital Management
55
Victory Capital Management
Texas
$146K -$5.14K -22 -2%
Truist Financial
56
Truist Financial
North Carolina
$145K +$157K +673 New
State Board of Administration of Florida Retirement System
57
State Board of Administration of Florida Retirement System
Florida
$128K
Stifel Financial
58
Stifel Financial
Missouri
$124K
ACM
59
ACT Capital Management
Pennsylvania
$108K
DekaBank Deutsche Girozentrale
60
DekaBank Deutsche Girozentrale
Germany
$103K +$9.35K +40 +10%
VEA
61
Virtus ETF Advisers
New York
$95K -$5.84K -25 -5%
Barclays
62
Barclays
United Kingdom
$95K +$103K +439 New
AB
63
Amalgamated Bank
New York
$81K +$88.6K +379 New
AF
64
Amalgamated Financial
New York
$81K +$88.6K +379 New
Legal & General Group
65
Legal & General Group
United Kingdom
$61K
Citigroup
66
Citigroup
New York
$53K -$147K -630 -72%
AIP
67
Ameritas Investment Partners
Nebraska
$45K
MLICM
68
Metropolitan Life Insurance Company (MetLife)
New York
$40.9K -$132K -566 -75%
Royal Bank of Canada
69
Royal Bank of Canada
Ontario, Canada
$36K -$78.8K -337 -67%
Rockefeller Capital Management
70
Rockefeller Capital Management
New York
$18K
LC
71
Lindbrook Capital
California
$15K
TRCT
72
Tower Research Capital (TRC)
New York
$12K +$935 +4 +8%
Daiwa Securities Group
73
Daiwa Securities Group
Japan
$4K
Osaic Holdings
74
Osaic Holdings
Arizona
$3K
SOW
75
State of Wyoming
Wyoming
$3K +$701 +3 +30%

TIL Hedge Fund Activity: Q1 2022 in Review

78 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in Instil Bio (TIL) for Q1 2022, worth a combined $1.27B — down 36% from $1.99B a quarter earlier.

Buyers outnumbered sellers: 11 funds opened new TIL positions and 10 closed out — a net gain of 1 holder — while 24 added to existing stakes and 19 trimmed.

The largest buyer was Fidelity Investments, adding an estimated $37.9M. The largest seller was Wellington Management Group, cutting an estimated $21M.

  • 78 institutional investors held Instil Bio (TIL) as of Q1 2022, up from 77 in Q4 2021.
  • Funds reported $1.27B of Instil Bio stock for Q1 2022, down 36% quarter-over-quarter.
  • 11 funds opened new Instil Bio positions in Q1 2022 and 10 closed out, a net change of +1 holder.
  • The largest Instil Bio buyer in Q1 2022 was Fidelity Investments, an estimated $37.9M added.
  • The largest Instil Bio seller in Q1 2022 was Wellington Management Group, an estimated $21M sold.

Based on aggregated 13F filings for Q1 2022.